Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform

Constance Delaby, Laia Muñoz, Soraya Torres, Alícia Nadal, Nathalie Le Bastard, Sylvain Lehmann, Alberto Lleó, Daniel Alcolea

    Research output: Contribution to journalArticleResearch

    3 Citations (Scopus)

    Abstract

    © 2018 Elsevier B.V. Objectives: To assess the potential influence of the ratio between the storage tube surface area and the volume of cerebrospinal fluid (CSF) (surface/volume) on the quantifications of four Alzheimer's disease (AD) biomarkers on the Lumipulse G600II automated platform. Methods: CSF samples of 10 consecutive patients were stored in 2 ml polypropylene tubes containing four different CSF volumes: 1.5 ml, 1 ml, 0.5 ml and 0.25 ml. Concentration of CSF Aβ1-42, Aβ1–40, t-Tau and p-Tau were measured in all aliquots using the LUMIPULSE G600II automated platform from Fujirebio. Results: Levels of CSF Aβ1-42 and Aβ1-40 were lower in samples stored with lower volumes (higher surface/volume ratios). This decrease was partly compensated by using the ratio Aβ1-42/Aβ1-40. Quantification of t-Tau and p-Tau were not influenced by this pre-analytical condition. Conclusion: The surface/volume ratio can potentially influence the results of amyloid AD biomarkers. It appears essential to take into account the surface/volume ratio of the storage tubes when quantifying CSF biomarkers in clinical routine.
    Original languageEnglish
    Pages (from-to)98-101
    JournalClinica Chimica Acta
    Volume490
    DOIs
    Publication statusPublished - 1 Mar 2019

    Keywords

    • Alzheimer's disease
    • Amyloid
    • Biomarkers
    • Cerebrospinal fluid
    • Lumipulse
    • Tau

    Fingerprint Dive into the research topics of 'Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform'. Together they form a unique fingerprint.

    Cite this